Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 15:9:444.
doi: 10.3389/fphar.2018.00444. eCollection 2018.

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity

Affiliations
Review

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity

Xinyu Yang et al. Front Pharmacol. .

Abstract

Anthracyclines are effective agents generally used to treat solid-tumor and hematologic malignancies. The use of anthracyclines for over 40 years has improved cancer survival statistics. Nevertheless, the clinical utility of anthracyclines is limited by its dose-dependent cardiotoxicity that adversely affects 10-30% of patients. Anthracycline-induced cardiotoxicity may be classified as acute/subacute or chronic/late toxicity and leads to devastating adverse effects resulting in poor quality of life, morbidity, and premature mortality. Traditional Chinese medicine has a history of over 2,000 years, involving both unique theories and substantial experience. Several studies have investigated the potential of natural products to decrease the cardiotoxic effects of chemotherapeutic agents on healthy cells, without negatively affecting their antineoplastic activity. This article discusses the mechanism of anthracycline-induced cardiotoxicity, and summarizes traditional Chinese medicine treatment for anthracycline-induced heart failure (HF), cardiac arrhythmia, cardiomyopathy, and myocardial ischemia in recent years, in order to provide a reference for the clinical prevention and treatment of cardiac toxicity.

Keywords: adverse effects; anthracyclines; antineoplastic; cardiac toxicity; traditional Chinese medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanism involved in traditional Chinese medicine treated on cardiotoxicity induced by anthracycline. ROS, reactive oxygen species; EF, ejection fraction; FS, fractional shortening; LV flow, left ventricular outflow; LVDF, left ventricular diastolic function; LVEF, left ventricle ejection fraction; LVFS, left ventricular fractional shortening; LV mass, left ventricular mass; CK, creatine kinase; Tnl, troponin I; BNP, brain natriuretic peptide; CK-MB, creatine kinase isoenzymes; cTnT, cardiac Troponin T, Rg3, GinsenosideRg3; SA, Salvianolic acids; TSNIIA-SS, Tanshinone IIA sodium sulfonate; P. grandiflorum, Platycodon grandiflorum; GB, Ginkgolide B; ZGCT, Zhi Gan Cao Tang; XG, Xinfuli Granule; WXKL, Wenxin Granule; SYKT, Sanyang Xuedai; SMY, Sheng-Mai Yin; NOS, nitric oxide synthase; SND, Sini decoction; GU, Glycyrrhiza Uralensis; MDA, malondialdehyde; SC, Schisandra chinensis; SOD, superoxide dismutase.

References

    1. Abbate A., Biondi-Zoccai G. G., Bussani R., Dobrina A., Camilot D., Feroce F., et al. . (2003). Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J. Am. Coll. Cardiol. 41, 753–760. 10.1016/S0735-1097(02)02959-5 - DOI - PubMed
    1. Adams J. D., Wang R. B., Yang J., Lien E. J. (2006). Preclinical and clinical examinations of Salvia miltiorrhiza and its Tanshinones in ischemic conditions. Chin. Med. 23, 1–15. 10.1186/1749-8546-1-3 - DOI - PMC - PubMed
    1. Adams J. M., Cory S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322–1326. 10.1126/science.281.5381.1322 - DOI - PubMed
    1. Aimin Z. (2011). Clinical observation on the therapeutic effect of ‘Wenxin Keli’ on the arrhythmia induced by anthracycline antineoplastic drugs. Anti Tumor Pharm. 1, 535–537.
    1. Appel J. M., Sander K., Hansen P. B., Møller J. E., Krarup-Hansen A., Gustafsson F. (2012). Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure. Congest. Heart Fail. 18, 291–294. 10.1111/j.1751-7133.2012.00291.x - DOI - PubMed